| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-05 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.13 | 2e-05 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-05 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-05 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-05 |